2019
DOI: 10.3389/fgene.2019.01182
|View full text |Cite|
|
Sign up to set email alerts
|

Graph Embedding Deep Learning Guides Microbial Biomarkers' Identification

Abstract: The microbiome-wide association studies are to figure out the relationship between microorganisms and humans, with the goal of discovering relevant biomarkers to guide disease diagnosis. However, the microbiome data is complex, with high noise and dimensions. Traditional machine learning methods are limited by the models' representation ability and cannot learn complex patterns from the data. Recently, deep learning has been widely applied to fields ranging from text processing to image recognition due to its … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
31
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(31 citation statements)
references
References 42 publications
(54 reference statements)
0
31
0
Order By: Relevance
“…Developing AI models in healthcare faces several legal regimes, such as federal regulations, state tort law, the Common Rule, and the Federal Trade Commission Act. In malpractice claims, owing to the use of AI black-box models in clinical workflows, the current legal system is not suitable [47,48]. Therefore, the responsibilities of different parties, including AI developers, the source of training data, clinicians, and suppliers who provide the AI system platform, must be clearly defined [1].…”
Section: Resultsmentioning
confidence: 99%
“…Developing AI models in healthcare faces several legal regimes, such as federal regulations, state tort law, the Common Rule, and the Federal Trade Commission Act. In malpractice claims, owing to the use of AI black-box models in clinical workflows, the current legal system is not suitable [47,48]. Therefore, the responsibilities of different parties, including AI developers, the source of training data, clinicians, and suppliers who provide the AI system platform, must be clearly defined [1].…”
Section: Resultsmentioning
confidence: 99%
“…The key first level dimensions of the SCS are as follows: (1) safety policies; 2 In malpractice claims, owing to the use of AI black-box models in clinical workflows, the current legal system is not suitable [56,57]. Therefore, the responsibilities of different parties, including AI developers, the source of training data, clinicians, and suppliers who provide the AI system platform, must be clearly defined [1].…”
Section: Resultsmentioning
confidence: 99%
“…For example, in Figure 4, a deep network with 3 hidden layers [49] using RapidMiner tool is illustrated. In a 3-layer network, low-level, middle-level and high-level or much more complex features are extracted in the first, second and third layers, respectively.…”
Section: ) Deep Learning Modelmentioning
confidence: 99%